OBJECTIVE: The Mental Health Parity and Addiction Equity Act requires insurance parity for mental health/substance use disorder and general medical services. Previous research found that parity did not increase mental health/substance use disorder spending and lowered out-of-pocket spending. Whether parity's effects differ by diagnosis is unknown. The authors examined this question in the context of parity implementation in the Federal Employees Health Benefits (FEHB) Program. METHOD: The authors compared mental health/substance use disorder treatment use and spending before and after parity (2000 and 2002, respectively) for two groups: FEHB enrollees diagnosed in 1999 with bipolar disorder, major depression, or adjustment disorder (N=19,094) and privately insured enrollees unaffected by the policy in a comparison national sample (N=10,521). Separate models were fitted for each diagnostic group. A difference-in-difference design was used to control for secular time trends and to better reflect the specific impact of parity on spending and utilization. RESULTS: Total spending was unchanged among enrollees with bipolar disorder and major depression but decreased for those with adjustment disorder (-$62, 99.2% CI=-$133, -$11). Out-of-pocket spending decreased for all three groups (bipolar disorder: -$148, 99.2% CI=-$217, -$85; major depression: -$100, 99.2% CI=-$123, -$77; adjustment disorder: -$68, 99.2% CI=-$84, -$54). Total annual utilization (e.g., medication management visits, psychotropic prescriptions, and mental health/substance use disorder hospitalization bed days) remained unchanged across all diagnoses. Annual psychotherapy visits decreased significantly only for individuals with adjustment disorders (-12%, 99.2% CI=-19%, -4%). CONCLUSIONS: Parity implemented under managed care improved financial protection and differentially affected spending and psychotherapy utilization across groups. There was some evidence that resources were preferentially preserved for diagnoses that are typically more severe or chronic and reduced for diagnoses expected to be less so.
OBJECTIVE: The Mental Health Parity and Addiction Equity Act requires insurance parity for mental health/substance use disorder and general medical services. Previous research found that parity did not increase mental health/substance use disorder spending and lowered out-of-pocket spending. Whether parity's effects differ by diagnosis is unknown. The authors examined this question in the context of parity implementation in the Federal Employees Health Benefits (FEHB) Program. METHOD: The authors compared mental health/substance use disorder treatment use and spending before and after parity (2000 and 2002, respectively) for two groups: FEHB enrollees diagnosed in 1999 with bipolar disorder, major depression, or adjustment disorder (N=19,094) and privately insured enrollees unaffected by the policy in a comparison national sample (N=10,521). Separate models were fitted for each diagnostic group. A difference-in-difference design was used to control for secular time trends and to better reflect the specific impact of parity on spending and utilization. RESULTS: Total spending was unchanged among enrollees with bipolar disorder and major depression but decreased for those with adjustment disorder (-$62, 99.2% CI=-$133, -$11). Out-of-pocket spending decreased for all three groups (bipolar disorder: -$148, 99.2% CI=-$217, -$85; major depression: -$100, 99.2% CI=-$123, -$77; adjustment disorder: -$68, 99.2% CI=-$84, -$54). Total annual utilization (e.g., medication management visits, psychotropic prescriptions, and mental health/substance use disorder hospitalization bed days) remained unchanged across all diagnoses. Annual psychotherapy visits decreased significantly only for individuals with adjustment disorders (-12%, 99.2% CI=-19%, -4%). CONCLUSIONS: Parity implemented under managed care improved financial protection and differentially affected spending and psychotherapy utilization across groups. There was some evidence that resources were preferentially preserved for diagnoses that are typically more severe or chronic and reduced for diagnoses expected to be less so.
Authors: Colleen L Barry; Jon R Gabel; Richard G Frank; Samantha Hawkins; Heidi H Whitmore; Jeremy D Pickreign Journal: Health Aff (Millwood) Date: 2003 Sep-Oct Impact factor: 6.301
Authors: Howard H Goldman; Richard G Frank; M Audrey Burnam; Haiden A Huskamp; M Susan Ridgely; Sharon-Lise T Normand; Alexander S Young; Colleen L Barry; Vanessa Azzone; Alisa B Busch; Susan T Azrin; Garrett Moran; Carolyn Lichtenstein; Margaret Blasinsky Journal: N Engl J Med Date: 2006-03-30 Impact factor: 91.245
Authors: Susan T Azrin; Haiden A Huskamp; Vanessa Azzone; Howard H Goldman; Richard G Frank; M Audrey Burnam; Sharon-Lise T Normand; M Susan Ridgely; Alexander S Young; Colleen L Barry; Alisa B Busch; Garrett Moran Journal: Pediatrics Date: 2007-02 Impact factor: 7.124
Authors: Mark Olfson; Steven C Marcus; Benjamin Druss; Lynn Elinson; Terri Tanielian; Harold Alan Pincus Journal: JAMA Date: 2002-01-09 Impact factor: 56.272
Authors: K John McConnell; Samuel H N Gast; M Susan Ridgely; Neal Wallace; Natalie Jacuzzi; Traci Rieckmann; Bentson H McFarland; Dennis McCarty Journal: Am J Psychiatry Date: 2011-09-02 Impact factor: 18.112
Authors: Rebecca L Haffajee; Michelle M Mello; Fang Zhang; Alisa B Busch; Alan M Zaslavsky; J Frank Wharam Journal: Med Care Date: 2019-04 Impact factor: 2.983
Authors: Benjamin Lê Cook; Michael Flores; Samuel H Zuvekas; Joseph P Newhouse; John Hsu; Rajan Sonik; Esther Lee; Vicki Fung Journal: Health Aff (Millwood) Date: 2020-05 Impact factor: 6.301
Authors: Haiden A Huskamp; Hillary Samples; Scott E Hadland; Emma E McGinty; Teresa B Gibson; Howard H Goldman; Susan H Busch; Elizabeth A Stuart; Colleen L Barry Journal: Psychiatr Serv Date: 2017-11-15 Impact factor: 3.084
Authors: Amber Gayle Thalmayer; Jessica M Harwood; Sarah Friedman; Francisca Azocar; L Amy Watson; Haiyong Xu; Susan L Ettner Journal: Health Serv Res Date: 2018-05-08 Impact factor: 3.402
Authors: Marguerite E Burns; Laura Dague; Brendan Saloner; Kristen Voskuil; Nam Hyo Kim; Natalia Serna Borrero; Kevin Look Journal: Health Serv Res Date: 2020-06-23 Impact factor: 3.402